COST-EFFECTIVENESS OF EVOLOCUMAB IN ATHEROSCLEROTIC CARDIOVASCULAR DISEASE PATIENTS WITH VARYING RISK PROFILES IN SWEDEN

被引：0
|
作者：
Lindgren, P. [1 ]
Hagstrom, E. [2 ]
van Hout, B. [3 ]
Villa, G. [4 ]
Pemberton-Ross, P. [4 ]
Arellano, J. [5 ]
Sibartie, M. [4 ]
Fonarow, G. C. [6 ]
机构：
[1] Karolinska Inst, Stockholm, Sweden
[2] Uppsala Univ, Uppsala, Sweden
[3] Univ Sheffield, Sheffield, S Yorkshire, England
[4] Amgen Europe GmbH, Rotkreuz, Switzerland
[5] Amgen Inc, Thousand Oaks, CA 91320 USA
[6] Univ Calif Los Angeles, Los Angeles, CA USA
来源：
VALUE IN HEALTH | 2019年 / 22卷
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCV40
引用
收藏
页码：S548 / S548
页数：1
相关论文
共 50 条
  • [41] COST-EFFECTIVENESS OF DISEASE MANAGEMENT PROGRAMS FOR CARDIOVASCULAR RISK AND COPD IN THE NETHERLANDS
    Tsiachristas, A.
    Burgers, L. T.
    Rutten-van Molken, M. P. M. H.
    VALUE IN HEALTH, 2014, 17 (07) : A498 - A498
  • [42] Cost-Effectiveness of Disease Management Programs for Cardiovascular Risk and COPD in The Netherlands
    Tsiachristas, Apostolos
    Burgers, Laura
    Rutten-van Molken, Maureen P. M. H.
    VALUE IN HEALTH, 2015, 18 (08) : 977 - 986
  • [43] Effectiveness and cost-effectiveness of interventions that cause weight loss and reduce the risk of cardiovascular disease
    Zomer, Ella
    Leach, Rachel
    Trimmer, Christine
    Lobstein, Tim
    Morris, Stephen
    James, William P.
    Finer, Nick
    DIABETES OBESITY & METABOLISM, 2017, 19 (01): : 118 - 124
  • [44] COST-EFFECTIVENESS OF DONEPEZIL IN ALZHEIMER'S DISEASE IN SWEDEN
    Mesterton, J.
    By, A.
    Sandelin, R.
    Jonsson, L.
    VALUE IN HEALTH, 2009, 12 (07) : A369 - A369
  • [45] Cost-effectiveness of ramipril in cardiovascular risk reduction for patients with diabetes mellitus
    Ganguly, R
    Parasuraman, T
    DIABETES, 2003, 52 : A261 - A262
  • [46] Statins for atherosclerotic cardiovascular disease prevention in people living with HIV in Thailand: a cost-effectiveness analysis
    Boettiger, David C.
    Newall, Anthony T.
    Chattranukulchai, Pairoj
    Chaiwarith, Romanee
    Khusuwan, Suwimon
    Avihingsanon, Anchalee
    Phillips, Andrew
    Bendavid, Eran
    Law, Matthew G.
    Kahn, James G.
    Ross, Jeremy
    Bautista-Arredondo, Sergio
    Kiertiburanakul, Sasisopin
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2020, 23
  • [47] A cost-effectiveness evaluation of amlodipine usage in patients with coronary artery disease in Sweden
    Doyle, JJ
    McGuire, A
    Arocho, R
    Arikian, S
    Casciano, J
    Svangren, P
    Casciano, R
    Kim, R
    Kugel, H
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2002, 56 (02) : 76 - 81
  • [48] COST-EFFECTIVENESS ANALYSIS AND BUDGET IMPACT MODEL OF LP(A) TESTING IN PORTUGUESE PATIENTS WITH ATHEROSCLEROTIC CARDIOVASCULAR DISEASE FOR SECONDARY PREVENTION
    Monge, S.
    Ferreira, C.
    Gomes-da-Costa, J.
    VALUE IN HEALTH, 2024, 27 (12)
  • [49] Cost-Effectiveness of LDL-C Lowering With Evolocumab in Patients With High Cardiovascular Risk in the United States (vol 39, pg 313, 2016)
    Gandra, Shravanthi R.
    CLINICAL CARDIOLOGY, 2016, 39 (10) : 621 - 621
  • [50] Cost-Effectiveness Analysis of Rivaroxaban in Chinese Patients With Stable Cardiovascular Disease
    Feng, Tianyu
    Zheng, Zhou
    Gao, Shang
    Xu, Jiaying
    Cao, Pen
    Jia, Huanhuan
    Yu, Xihe
    FRONTIERS IN PHARMACOLOGY, 2022, 13
12345